Red day on Wednesday for Biolife Sciences IncStockInvest.us, 4 months ago
No changes to the price of Biolife Sciences Inc stock on the last trading day (Wednesday, 12th Jan 2022). During the day the stock fluctuated 0% from a day low at $1.07 to a day high of $1.07. The price has fallen in 4 of the last 10 days, but is still up by 15.89% over the past 2 weeks.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.Given the current short-term trend, the stock is expected to rise 75.26% during the next 3 months and, with a 90% probability hold a price between $1.12 and $4.54 at the end of this 3-month period.
A buy signal was issued from a pivot bottom point on Tuesday, January 11, 2022, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biolife Sciences Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.22 and $1.21. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
On the downside, the stock finds support just below today's level from accumulated volume at $0.98 and $0.92.There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Biolife Sciences Inc finds support just below today's level at $0.98. If this is broken, then the next support from accumulated volume will be at $0.92 and $0.84.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had a daily average volatility of 19.94%
Biolife Sciences Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.Check full Biolife Sciences Inc forecast and analysis here.